Home / FRX.TO : TSX

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does FRX.TO make money? Does FRX.TO have pricing power? What's the Earnings Whisper? Will FRX.TO profit more as the business scales? What is FRX.TO's management track record? Is FRX.TO's current price justified?

Fennec Pharmaceuticals Inc.

CAD 17.1 +$6.69 (+64.27%)

TSX · 10 Sep 2026 20:10 UTC

Previous Close

CAD 17.1

Day Range

CAD 17.1 - CAD 17.1

Year Range

CAD 7.59CAD 17.64

Market Cap

594M

AVG Volume

1.05K

Trailing/Forward PE

-84.31/18.65

PEG ratio

-0.36

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Toronto Stock Exchange

Revenue (USD)

FRX.TO Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	17.87M
26 Q1	15.07M
25 Q4	13.99M
25 Q3	12.46M
25 Q2	9.65M
25 Q1	8.75M
24 Q4	7.92M
24 Q3	6.97M
24 Q2	7.26M
24 Q1	25.38M

Net Income (USD)

FRX.TO Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	1.97M
26 Q1	200.48K
25 Q4	-5.22M
25 Q3	-638K
25 Q2	-3.15M
25 Q1	-1.17M
24 Q4	-1.99M
24 Q3	-5.74M
24 Q2	-5.55M
24 Q1	12.84M

Operating Income (USD)

FRX.TO Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	1.74M
26 Q1	-118.69K
25 Q4	-3.06M
25 Q3	-189K
25 Q2	-2.73M
25 Q1	-808K
24 Q4	-934K
24 Q3	-5.2M
24 Q2	-5.04M
24 Q1	13.74M

EBITDA (USD)

FRX.TO EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	1.76M
26 Q1	234K
25 Q4	-3.06M
25 Q3	-1K
25 Q2	-2.53M
25 Q1	-547K
24 Q4	-628K
24 Q3	-4.68M
24 Q2	-4.48M
24 Q1	14.59M

Cash Flows (USD)

FRX.TO Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	38.69K
26 Q1	2.37M
25 Q4	-8.04M
25 Q3	1.49M
25 Q2	-3.69M
25 Q1	-4.32M
24 Q4	-1.47M
24 Q3	-2.21M
24 Q2	-8.39M
24 Q1	39.05M

EPS (USD)

FRX.TO EPS (USD) by quarter
Period	EPS (USD)
26 Q2	0.05
26 Q1	0.01
25 Q4	-0.17
25 Q3	-0.02
25 Q2	-0.11
25 Q1	-0.04
24 Q4	-0.07
24 Q3	-0.21
24 Q2	-0.2
24 Q1	0.41

Expenses (USD)

FRX.TO Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	15.41M
26 Q1	14.62M
25 Q4	15.26M
25 Q3	11.99M
25 Q2	11.42M
25 Q1	9.19M
24 Q4	8.19M
24 Q3	10.82M
24 Q2	11.69M
24 Q1	11.08M

Cash & Debt (USD)

FRX.TO Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	41.23M
26 Q1	40.08M
25 Q4	36.72M
25 Q3	21.93M
25 Q2	18.7M
25 Q1	22.68M
24 Q4	26.63M
24 Q3	40.32M
24 Q2	43.05M
24 Q1	51.18M

Debt ratios

FRX.TO Debt ratios by quarter
Period	Debt ratios
26 Q2	38.6
26 Q1	7.47
25 Q4	5.98
25 Q3	1.03
25 Q2	-0.08
25 Q1	0.32
24 Q4	-1.52
24 Q3	-2.2
24 Q2	-1.51
24 Q1	-2.7

Margins

FRX.TO Margins by quarter
Period	Margins
26 Q2	95.97%
26 Q1	96.23%
25 Q4	87.2%
25 Q3	94.7%
25 Q2	89.98%
25 Q1	95.74%
24 Q4	91.56%
24 Q3	80.54%
24 Q2	91.63%
24 Q1	97.83%

Return on Capital

FRX.TO Return on Capital by quarter
Period	Return on Capital
26 Q2	4.65%
26 Q1	0.53%
25 Q4	-14.9%
25 Q3	14.22%
25 Q2	42.24%
25 Q1	19.81%
24 Q4	33.8%
24 Q3	110.91%
24 Q2	409.21%
24 Q1	425.91%

Shares Outstanding

FRX.TO Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	34.55M
26 Q1	34.34M
25 Q4	31.18M
25 Q3	27.89M
25 Q2	27.66M
25 Q1	27.58M
24 Q4	27.46M
24 Q3	27.3M
24 Q2	27.3M
24 Q1	27.05M

Book Value Per Share (USD)

FRX.TO Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	1.23
26 Q1	1.09
25 Q4	1.12
25 Q3	-0.16
25 Q2	-0.27
25 Q1	-0.21
24 Q4	-0.21
24 Q3	-0.19
24 Q2	-0.05
24 Q1	0.11

Total Assets (USD)

FRX.TO Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	75.72M
26 Q1	71.64M
25 Q4	70.07M
25 Q3	49.21M
25 Q2	44.88M
25 Q1	46.4M
24 Q4	44.95M
24 Q3	58.92M
24 Q2	63.16M
24 Q1	69.19M

PE Ratio

FRX.TO PE Ratio by quarter
Period	PE Ratio
Dec 24	61.86
Dec 24	59.53
Dec 24	60.89
Dec 24	61.65
Nov 24	60.53
Nov 24	52.51
Nov 24	40.04
Nov 24	42.93
Nov 24	43.52
Oct 24	42.19
Oct 24	46.66
Oct 24	41.79
Oct 24	46.04
Sep 24	49.41
Sep 24	49.7
Sep 24	51.67
Sep 24	50.04
Aug 24	52.12
Aug 24	54.72
Aug 24	54.04
Aug 24	55.08
Aug 24	54.71
Jul 24	63.45
Jul 24	61.24
Jul 24	60.75
Jul 24	55.56

Free Cash Flow Yield

FRX.TO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-1.85%
Sep 26	-1.82%
Aug 26	-1.87%
Aug 26	-2.03%
Aug 26	-1.87%
Aug 26	-1.99%
Jul 26	-2.32%
Jul 26	-2.27%
Jul 26	-2.26%
Jul 26	-2.24%
Jul 26	-2.12%
Jun 26	-4.35%
Jun 26	-5.21%
Jun 26	-5.27%
Jun 26	-5.12%
May 26	-4.71%
May 26	-4.71%
May 26	-4.82%
May 26	-6.62%
May 26	-7.15%
Apr 26	-6.82%
Apr 26	-6.8%
Apr 26	-7.98%
Apr 26	-7.28%
Mar 26	-4.77%
Mar 26	-3.89%
Mar 26	-3.66%
Mar 26	-3.75%
Feb 26	-3.35%
Feb 26	-3.26%
Feb 26	-3.71%
Feb 26	-3.63%
Jan 26	-3.82%
Jan 26	-3.75%
Jan 26	-3.79%
Jan 26	-3.67%
Jan 26	-3.78%
Dec 25	-3.68%
Dec 25	-3.8%
Dec 25	-3.72%
Dec 25	-3.75%
Nov 25	-3.58%
Nov 25	-3.59%
Nov 25	-3.6%
Nov 25	-5.07%
Oct 25	-5.1%
Oct 25	-4.66%
Oct 25	-5.11%
Oct 25	-4.81%
Oct 25	-4.28%
Sep 25	-6.57%
Sep 25	-6.86%
Sep 25	-6.44%
Sep 25	-6.62%
Aug 25	-6.6%
Aug 25	-6.88%
Aug 25	-6.93%
Aug 25	-7.17%
Aug 25	-7.44%
Jul 25	-6.79%
Jul 25	-7%
Jul 25	-6.72%
Jul 25	-6.64%
Jun 25	11.9%
Jun 25	12.53%
Jun 25	12.4%
Jun 25	11.41%
May 25	12%
May 25	12.1%
May 25	14.44%
May 25	15.14%
May 25	15.87%
Apr 25	19.22%
Apr 25	19.2%
Apr 25	19.32%
Apr 25	18.76%
Mar 25	13.43%
Mar 25	12.96%
Mar 25	13.1%
Mar 25	12.64%
Feb 25	12.32%
Feb 25	12.93%
Feb 25	12.51%
Feb 25	13.69%
Jan 25	13.5%
Jan 25	13.77%
Jan 25	15.68%
Jan 25	14.51%
Jan 25	14.14%
Dec 24	13.62%
Dec 24	14.15%
Dec 24	13.83%
Dec 24	13.66%
Nov 24	13.92%
Nov 24	16.04%
Nov 24	21.04%
Nov 24	19.62%
Nov 24	19.36%
Oct 24	19.97%
Oct 24	18.05%

Price to Sales

FRX.TO Price to Sales by quarter
Period	Price to Sales
Sep 26	8.31
Sep 26	8.45
Aug 26	8.21
Aug 26	7.55
Aug 26	8.23
Aug 26	7.71
Jul 26	6.63
Jul 26	6.77
Jul 26	6.81
Jul 26	6.88
Jul 26	7.24
Jun 26	7.47
Jun 26	6.23
Jun 26	6.16
Jun 26	6.34
May 26	6.89
May 26	6.89
May 26	6.73
May 26	4.9
May 26	4.54
Apr 26	4.76
Apr 26	4.77
Apr 26	4.07
Apr 26	4.46
Mar 26	4.31
Mar 26	5.29
Mar 26	5.62
Mar 26	5.49
Feb 26	6.14
Feb 26	6.32
Feb 26	5.55
Feb 26	5.68
Jan 26	5.39
Jan 26	5.49
Jan 26	5.43
Jan 26	5.61
Jan 26	5.45
Dec 25	5.59
Dec 25	5.41
Dec 25	5.53
Dec 25	5.49
Nov 25	5.75
Nov 25	5.74
Nov 25	5.72
Nov 25	6.92
Oct 25	6.88
Oct 25	7.52
Oct 25	6.87
Oct 25	7.3
Oct 25	8.19
Sep 25	8.07
Sep 25	7.73
Sep 25	8.24
Sep 25	8
Aug 25	8.03
Aug 25	7.71
Aug 25	7.65
Aug 25	7.39
Aug 25	7.12
Jul 25	7.81
Jul 25	7.57
Jul 25	7.89
Jul 25	7.98
Jun 25	4.77
Jun 25	4.53
Jun 25	4.58
Jun 25	4.98
May 25	4.73
May 25	4.69
May 25	3.93
May 25	3.75
May 25	3.58
Apr 25	2.95
Apr 25	2.96
Apr 25	2.94
Apr 25	3.03
Mar 25	3.56
Mar 25	3.69
Mar 25	3.65
Mar 25	3.78
Feb 25	3.88
Feb 25	3.7
Feb 25	3.82
Feb 25	3.49
Jan 25	3.54
Jan 25	3.47
Jan 25	3.05
Jan 25	3.3
Jan 25	3.38
Dec 24	3.46
Dec 24	3.33
Dec 24	3.41
Dec 24	3.45
Nov 24	3.39
Nov 24	2.94
Nov 24	2.24
Nov 24	2.4
Nov 24	2.43
Oct 24	2.36
Oct 24	2.61

EV/EBITDA

FRX.TO EV/EBITDA by quarter
Period	EV/EBITDA
Jun 25	45.72
Jun 25	43.37
Jun 25	43.83
Jun 25	47.78
May 25	45.36
May 25	44.97
May 25	37.41
May 25	35.62
May 25	33.91
Apr 25	27.74
Apr 25	27.77
Apr 25	27.59
Apr 25	28.45
Mar 25	44.91
Mar 25	46.62
Mar 25	46.09
Mar 25	47.85
Feb 25	49.14
Feb 25	46.72
Feb 25	48.39
Feb 25	44.02
Jan 25	44.68
Jan 25	43.74
Jan 25	38.14
Jan 25	41.42
Jan 25	42.55
Dec 24	21.12
Dec 24	20.27
Dec 24	20.77
Dec 24	21.05
Nov 24	20.64
Nov 24	17.7
Nov 24	13.14
Nov 24	14.2
Nov 24	14.42
Oct 24	13.93
Oct 24	15.56
Oct 24	13.78
Oct 24	15.34
Sep 24	16.45
Sep 24	16.56
Sep 24	17.32
Sep 24	16.69
Aug 24	17.5
Aug 24	18.5
Aug 24	18.24
Aug 24	18.64
Aug 24	18.5
Jul 24	21.89
Jul 24	21.03
Jul 24	20.84
Jul 24	18.83

Price/Operating Cashflow

FRX.TO Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Jun 25	8.4
Jun 25	7.98
Jun 25	8.07
Jun 25	8.77
May 25	8.34
May 25	8.27
May 25	6.92
May 25	6.61
May 25	6.3
Apr 25	5.2
Apr 25	5.21
Apr 25	5.18
Apr 25	5.33
Mar 25	7.45
Mar 25	7.72
Mar 25	7.63
Mar 25	7.91
Feb 25	8.11
Feb 25	7.73
Feb 25	8
Feb 25	7.31
Jan 25	7.41
Jan 25	7.26
Jan 25	6.38
Jan 25	6.89
Jan 25	7.07
Dec 24	7.34
Dec 24	7.07
Dec 24	7.23
Dec 24	7.32
Nov 24	7.19
Nov 24	6.23
Nov 24	4.75
Nov 24	5.1
Nov 24	5.17
Oct 24	5.01
Oct 24	5.54
Oct 24	4.96
Oct 24	5.46
Sep 24	5.11
Sep 24	5.14
Sep 24	5.35
Sep 24	5.18
Aug 24	5.39
Aug 24	5.66
Aug 24	5.59
Aug 24	5.7
Aug 24	5.66
Jul 24	6.57
Jul 24	6.34
Jul 24	6.29
Jul 24	5.75

Price to Book

FRX.TO Price to Book by quarter
Period	Price to Book
Sep 26	11.32
Sep 26	11.51
Aug 26	11.17
Aug 26	10.28
Aug 26	11.2
Aug 26	10.5
Jul 26	9.03
Jul 26	9.22
Jul 26	9.27
Jul 26	9.36
Jul 26	9.85
Jun 26	9.55
Jun 26	7.98
Jun 26	7.88
Jun 26	8.12
May 26	8.82
May 26	8.81
May 26	8.61
May 26	6.28
May 26	5.81
Apr 26	6.09
Apr 26	6.11
Apr 26	5.21
Apr 26	5.71
Sep 24	46.62
Sep 24	46.9
Sep 24	48.75
Sep 24	47.21
Aug 24	49.18
Aug 24	51.63
Aug 24	50.99
Aug 24	51.97
Aug 24	51.63
Jul 24	59.87
Jul 24	57.78
Jul 24	57.32
Jul 24	52.43
Mar 23	70.49
Mar 23	76.63
Mar 23	85.09
Mar 23	85.17
Feb 23	83.5
Feb 23	87.79
Feb 23	90.53
Feb 23	91.25
Jan 23	89.93
Jan 23	92.32
Jan 23	100.2
Jan 23	92.14
Dec 22	90.02
Dec 22	30.4
Dec 22	29.84
Dec 22	29.2
Dec 22	29.41
Nov 22	29.19
Nov 22	26.21
Nov 22	24.49
Nov 22	25.77
Oct 22	25.79
Oct 22	25.35
Oct 22	24.17
Oct 22	23.9
Sep 22	24.6
Sep 22	16.12
Sep 22	14.06
Sep 22	15.78
Sep 22	15.43
Aug 22	13.28
Aug 22	13.53
Aug 22	14.3
Aug 22	13.8
Jul 22	14.34
Jul 22	14.4
Jul 22	13.94
Jul 22	13.17
Jun 22	11.73
Jun 22	9.3
Jun 22	9.18
Jun 22	8.95
Jun 22	9.5
May 22	8.69
May 22	9.51
May 22	8.9
May 22	9.58
Apr 22	10.26
Apr 22	9.78
Apr 22	10.48
Apr 22	10.52
Apr 22	9.62
Mar 22	8.04
Mar 22	7.51
Mar 22	7.42
Mar 22	7.04
Feb 22	7.5
Feb 22	6.57
Feb 22	7.08
Feb 22	6.37
Jan 22	5.97
Jan 22	6.34
Jan 22	6.2

No video analysis for this stock yet. Request one from our team.

AI Analysis

Fennec Pharmaceuticals Inc.

Video analysis: FRX.TO

Similar companies